Rafferty Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.06M | Buy |
|
|||||
|
2025
Q3 | $704K | Buy |
|
|||||
|
2025
Q2 | $530K | Buy |
|
|||||
|
2025
Q1 | $303K | Sell |
|
|||||
|
2024
Q4 | $461K | Buy |
|
|||||
|
2024
Q3 | $508K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $701K | Sell |
|
|||||
|
2021
Q4 | $849K | Buy |
|
|||||
|
2021
Q3 | $674K | Sell |
|
|||||
|
2021
Q2 | $1.43M | Buy |
|
|||||
|
2021
Q1 | $470K | Buy |
|